459 related articles for article (PubMed ID: 34122349)
1. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
2. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
[TBL] [Abstract][Full Text] [Related]
3. High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment.
Sun TC; Zhou SJ; Song LL; Li JH; Chen X; Tian L
JBRA Assist Reprod; 2021 Apr; 25(2):266-271. PubMed ID: 33710839
[TBL] [Abstract][Full Text] [Related]
4. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology.
Tal R; Seifer CM; Khanimov M; Seifer DB; Tal O
Reprod Biol Endocrinol; 2020 Mar; 18(1):20. PubMed ID: 32156287
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study.
Hou Y; Wang L; Li Y; Ai J; Tian L
Sci Rep; 2023 Feb; 13(1):2127. PubMed ID: 36746984
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone is a predictor of medium-term cumulative live birth following in vitro fertilization/intracytoplasmic sperm injection: A retrospective study.
Kien Nguyen D; O'Leary S; Abdelhafez Gadalla M; Roberts B; Alvino H; Tremellen KP
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():220-225. PubMed ID: 35395615
[TBL] [Abstract][Full Text] [Related]
7. IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels.
Zhang B; Meng Y; Jiang X; Liu C; Zhang H; Cui L; Chen ZJ
Reprod Biol Endocrinol; 2019 Jul; 17(1):58. PubMed ID: 31311571
[TBL] [Abstract][Full Text] [Related]
8. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
9. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters.
De Vos M; Pareyn S; Drakopoulos P; Raimundo JM; Anckaert E; Santos-Ribeiro S; Polyzos NP; Tournaye H; Blockeel C
Reprod Biomed Online; 2018 Aug; 37(2):163-171. PubMed ID: 29778554
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cumulative outcomes and influencing factors of patients with discrepancies between age and AMH levels in the early follicular phase prolonged protocol.
Wang K; Guan Y; Zhang Y; Jia R; Wu S; Yao Z; Zhang M; Li Z
Front Endocrinol (Lausanne); 2023; 14():1098131. PubMed ID: 36967754
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients.
Guo Y; Jiang H; Hu S; Liu S; Li F; Jin L
J Ovarian Res; 2021 Aug; 14(1):111. PubMed ID: 34454544
[TBL] [Abstract][Full Text] [Related]
12. Cumulative live birth rates in low-prognosis women.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
[TBL] [Abstract][Full Text] [Related]
13. Association of serum anti-Müllerian hormone and other factors with cumulative live birth rate following IVF.
Hu KL; Liu FT; Xu H; Li R; Qiao J
Reprod Biomed Online; 2020 May; 40(5):675-683. PubMed ID: 32268980
[TBL] [Abstract][Full Text] [Related]
14. Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI.
He Y; Li R; Yin J; Yang Z; Wang Y; Chen L; Yang S; Qiao J
Front Endocrinol (Lausanne); 2023; 14():1204623. PubMed ID: 37693353
[TBL] [Abstract][Full Text] [Related]
15. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
16. Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Yuwen T; Yang Z; Cai G; Feng G; Liu Q; Fu H
Reprod Biol Endocrinol; 2023 Oct; 21(1):95. PubMed ID: 37872575
[TBL] [Abstract][Full Text] [Related]
17. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
[TBL] [Abstract][Full Text] [Related]
18. High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome.
Su N; Zhan J; Xie M; Zhao Y; Huang C; Wang S; Liao L; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1123125. PubMed ID: 37388214
[TBL] [Abstract][Full Text] [Related]
19. Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.
Guan Y; Kong P; Xiao Z; Zhang J; He J; Geng W; Yan J; Sun S; Mu M; Du X; Wang X
Front Endocrinol (Lausanne); 2021; 12():728051. PubMed ID: 35111134
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.
Li Z; Jia R; Wang K; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2022; 13():938500. PubMed ID: 35992097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
